Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rafel Masiá"'
Autor:
Silvia Pérez-Fernández, I Palomo, Irene R. Dégano, Rafael Ramos, Helena Tizón-Marcos, Roberto Elosua, J. Marrugat, Rafel Masiá, Isaac Subirana, A Camps-Vilaro, B Vaquerizo, N Farre, Juan Sanchis, Joan Sala
Publikováno v:
European Journal of Preventive Cardiology. 28
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): CIBERCV of cardiovascular diseases; CIBERESP. OnBehalf REGICOR investigators Background Although myocardial infarction (MI) severity t
Autor:
Saray Heredia, Sonia Gaixas, Joan Sala, Daniel Muñoz-Aguayo, Joan Vila, Jordi Bruguera, Lluis Molina, Montserrat Fitó, Marta Tomás, Gemma Blanchart, Miquel Gómez, Rafel Masiá
Publikováno v:
Journal of Cardiovascular Medicine. 15:417-422
AIM To determine whether circulating antibodies against oxidized low-density lipoprotein (LDL; OLAB) levels are associated with acute myocardial infarction (AMI) in individuals without classical cardiovascular risk factors. METHODS A case-control stu
Autor:
Miquel Gómez, Jaume Marrugat, Joan Vila, Lluis Molina, Roberto Elosua, María Isabel Covas, Joan Sala, Rafel Masiá, Montserrat Fitó, Jordi Bruguera
Publikováno v:
Atherosclerosis. 232:134-140
Objectives To assess 1) the association of lipid oxidation biomarkers with 10-year coronary artery disease (CAD) events and subclinical atherosclerosis, and 2) the reclassification capacity of these biomarkers over Framingham-derived CAD risk functio
Autor:
Eric de Groot, Rafel Masiá, Miguel López-Botet, Monica Guma, Neus Romo, Montserrat Fitó, Joan Sala, C. García, Joan Vila, Rafel Ramos, Roberto Elosua, Jordi Bruguera, Isaac Subirana, Aura Muntasell, Jaume Marrugat
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology, 31(10), 2314-U360. Lippincott Williams and Wilkins
Objective— The contribution of human cytomegalovirus (HCMV) to vascular disease may depend on features of the immune response not reflected by the detection of specific antibodies. Persistent HCMV infection in healthy blood donors has been associat
Autor:
Marta Tomás, Gavin Lucas, Rafel Masiá, Michel Zabalza, Joan Sala, Carla Lluis-Ganella, Isaac Subirana, Roberto Elosua, Ramon Brugada, Jaume Marrugat
Publikováno v:
Heart. 98:100-108
Aims To perform a meta-analysis of the association between CYP2C19 loss- and gain-of-function variants and cardiovascular outcomes and bleeding in patients with coronary artery disease treated with clopidogrel, and to explore the causes of heterogene
Autor:
Ramon Brugada, Rafel Ramos, Juan Sanchis, Rafel Masiá, Joan Sala, María Grau, Magda Heras, Joan Vila, Daniel Bosch, Roberto Elosua, Isaac Subirana, Jaume Marrugat
Publikováno v:
Revista Española de Cardiología (English Edition). 64:96-104
Introduction and objectives: To determine the effect of opening an on-site diagnostic catheterization facility on 30-day and 2-year mortality rates in patients with myocardial infarction (MI). Methods: The study included 1539 consecutive MI patients
Autor:
Miquel Quesada, Joan Sala, María Grau, Pascual Solanas, Anna Ponjoan, Maite Alzamora, Ramon Brugada, Ferran Cordón, Rafel Ramos, Carlos Cerezo, Guillem Pera, Ruth Martí, Rafel Masiá, Roberto Elosua, Jaume Marrugat, Fernando Rigo, Rosa Forés, José Miguel Baena-Díez, Isaac Subirana
Publikováno v:
Atherosclerosis. 214:474-479
The recommendation of screening with ankle brachial index (ABI) in asymptomatic individuals is controversial. The aims of the present study were to develop and validate a pre-screening test to select candidates for ABI measurement in the Spanish popu
Autor:
Jordi Bruguera, Vicente Valle, Rafel Masiá, Helena Martí, Joan Sala, Lluis Molina, Roberto Elosua, Ginés Sanz, Isaac Subirana, Cosme García-García, Jaume Marrugat
Publikováno v:
Revista Española de Cardiología. 63:1136-1144
Introduccion y objetivos. El tratamiento del infarto agudo de miocardio (IAM) ha cambiado considerablemente en los ultimos anos. El objetivo es determinar la evolucion de la mortalidad intrahospitalaria y del pronostico a 6 meses de los pacientes que
Autor:
Jaume Marrugat, Vicente Valle, Helena Martí, Jordi Bruguera, Joan Sala, Roberto Elosuaf, Cosme García-García, Lluis Molina, Rafel Masiá, Ginés Sanz, Isaac Subirana
Publikováno v:
Revista Española de Cardiología (English Edition). 63:1136-1144
Treatment of acute myocardial infarction (AMI) has changed considerably in recent years. The objective of this study was to investigate differences in in-hospital mortality and 6-month outcomes after a first AMI between patients who participated in t
Autor:
Joan Vila, Montserrat Fitó, María Grau, Joan Sala, Carlos Cerezo, Ferran Cordón, Roberto Elosua, Rafel Ramos, Isaac Subirana, Dolors Juvinyà, Jaume Marrugat, María Isabel Covas, Rafel Masiá, Pascual Solanas
Publikováno v:
European Journal of Cardiovascular Prevention & Rehabilitation. 14:653-659
Background High prevalence of cardiovascular risk factors has been observed in Spain along with low incidence of acute myocardial infarction. Our objective was to determine the trends of cardiovascular risk factor prevalence between 1995 and 2005 in